Sun Pharma Q2 net profit up 11%, above expectations1 min read . Updated: 01 Nov 2022, 03:05 PM IST
- Sun Pharma shares were trading more than 2% higher on the BSE in afternoon deals
Drugmaker Sun Pharma on Tuesday reported an over 11% rise in its consolidated net profit for Q2 FY23 at ₹2,262 crore, on higher sales in the domestic market, as compared to ₹2,047 crore year-on-year (YoY). Analysts expected the company to report profit of ₹1,983 crore, according to Refinitiv IBES data.
Select your Category